Trial Profile
Evaluation of the Combination of Docetaxel (Taxotere)/ Carboplatin in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Apr 2023
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Carboplatin
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 06 Jun 2007 Status changed from in progress to completed
- 07 Sep 2005 New trial record.